We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$12.7M
2
RPAR icon
RPAR Risk Parity ETF
RPAR
+$5.28M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$4.15M
4
BAC icon
Bank of America
BAC
+$4.06M
5
NVDA icon
NVIDIA
NVDA
+$3.33M

Top Sells

Rank Stock Value
1
ORMP icon
Oramed Pharmaceuticals
ORMP
+$4.61M
2
DBC icon
Invesco DB Commodity Index Tracking Fund
DBC
+$4.54M
3
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$4.45M
4
IEO icon
iShares US Oil & Gas Exploration & Production ETF
IEO
+$4.15M
5
AGEN
Agenus
AGEN
+$2.89M

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNDE icon
2326
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.81B
$1.61K ﹤0.01%
62
– –
BLFS icon
2327
BioLife Solutions
BLFS
$1.7B
$1.61K ﹤0.01%
74
-15
-17% -$337
DRVN icon
2328
Driven Brands
DRVN
$2.2B
$1.61K ﹤0.01%
+53
New +$1.5K
WMS icon
2329
Advanced Drainage Systems
WMS
$10.9B
$1.6K ﹤0.01%
19
-16
-46% -$1.41K
NETI
2330
DELISTED
Eneti Inc.
NETI
$1.6K ﹤0.01%
171
-166
-49% -$1.66K
ARKO icon
2331
ARKO Corp
ARKO
$635M
$1.59K ﹤0.01%
+187
New +$1.56K
VRT icon
2332
Vertiv
VRT
$105B
$1.59K ﹤0.01%
111
-71
-39% -$1.04K
CNK icon
2333
Cinemark Holdings
CNK
$4.32B
$1.58K ﹤0.01%
107
+90
+529% +$1.09K
SCS
2334
DELISTED
Steelcase
SCS
$1.58K ﹤0.01%
188
+38
+25% +$292
KLIC icon
2335
Kulicke & Soffa
KLIC
$4.78B
$1.58K ﹤0.01%
30
– –
MBUU icon
2336
Malibu Boats
MBUU
$567M
$1.58K ﹤0.01%
28
– –
FCN icon
2337
FTI Consulting
FCN
$4.18B
$1.58K ﹤0.01%
8
+6
+300% +$1.04K
PETS icon
2338
PetMed Express
PETS
$42.3M
$1.57K ﹤0.01%
97
– –
LQDA icon
2339
Liquidia Corp
LQDA
$8.02B
$1.55K ﹤0.01%
225
– –
KPTI icon
2340
Karyopharm Therapeutics
KPTI
$48M
$1.55K ﹤0.01%
+27
New +$1.33K
MXCT icon
2341
MaxCyte
MXCT
$126M
$1.55K ﹤0.01%
+313
New +$1.54K
CLDX icon
2342
Celldex Therapeutics
CLDX
$3.28B
$1.55K ﹤0.01%
43
-36
-46% -$1.55K
CSTL icon
2343
Castle Biosciences
CSTL
$979M
$1.54K ﹤0.01%
68
-12
-15% -$293
FCF icon
2344
First Commonwealth Financial
FCF
$2.17B
$1.54K ﹤0.01%
124
– –
TERN
2345
DELISTED
Terns Pharmaceuticals
TERN
$1.54K ﹤0.01%
+130
New +$1.24K
DDS icon
2346
Dillards
DDS
$9.56B
$1.54K ﹤0.01%
5
-5
-50% -$1.78K
TPIC
2347
DELISTED
TPI Composites
TPIC
$1.51K ﹤0.01%
+116
New +$1.48K
ETWO
2348
DELISTED
E2open Parent Holdings
ETWO
$1.51K ﹤0.01%
259
-578
-69% -$3.49K
RCKT icon
2349
Rocket Pharmaceuticals
RCKT
$394M
$1.51K ﹤0.01%
88
– –
TRMK icon
2350
Trustmark
TRMK
$2.75B
$1.51K ﹤0.01%
61
– –
92 93
94
95 96

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.